Structural stabilization of the intrinsically disordered SARS-CoV-2 N by binding to RNA sequences engineered from the viral genome fragment Christopher.Koski@bruker.com Structural stabilization of the intrinsically disordered SARS-CoV-2 N by binding to RNA sequences engineered from the viral genome fragment Read More »
Multimodal evaluation of cerebrospinal fluid from breast cancer leptomeningeal metastases using circulating tumor cell detection, single-cell sequencing, and proteomics Christopher.Koski@bruker.com Multimodal evaluation of cerebrospinal fluid from breast cancer leptomeningeal metastases using circulating tumor cell detection, single-cell sequencing, and proteomics Read More »
Ex vivo single‐cell profiling of acute myocardial infarction patients reveals disproportionate CD66b+ cell secretion response Christopher.Koski@bruker.com Ex vivo single‐cell profiling of acute myocardial infarction patients reveals disproportionate CD66b+ cell secretion response Read More »
Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma Christopher.Koski@bruker.com Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma Read More »
Multi-pronged analysis of pediatric low-grade glioma and ganglioglioma reveals a unique tumor microenvironment associated with BRAF alterations Christopher.Koski@bruker.com Multi-pronged analysis of pediatric low-grade glioma and ganglioglioma reveals a unique tumor microenvironment associated with BRAF alterations Read More »
A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial Christopher.Koski@bruker.com A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial Read More »
Osteoclast-expanded supercharged NK cells perform superior antitumour effector functions Christopher.Koski@bruker.com Osteoclast-expanded supercharged NK cells perform superior antitumour effector functions Read More »
CAR-T cells targeting CD155 reduce tumor burden in preclinical models of leukemia and solid tumors Christopher.Koski@bruker.com CAR-T cells targeting CD155 reduce tumor burden in preclinical models of leukemia and solid tumors Read More »
A novel CD3ε fusion receptor allows use of T-cell engagers on TCR-less allogeneic CAR T cells to improve activity and prevent antigen escape Christopher.Koski@bruker.com A novel CD3ε fusion receptor allows use of T-cell engagers on TCR-less allogeneic CAR T cells to improve activity and prevent antigen escape Read More »
Reprogramming the neuroblastoma tumor immune microenvironment to enhance GPC2 CAR T cells Christopher.Koski@bruker.com Reprogramming the neuroblastoma tumor immune microenvironment to enhance GPC2 CAR T cells Read More »
